# Precutaneous High Risk Patent Foramen Ovale to Treat Migraine Headaches

> **NCT02777359** · PHASE2 · UNKNOWN · sponsor: **First Affiliated Hospital Xi'an Jiaotong University** · enrollment: 100 (estimated)

## Conditions studied

- Patent Foramen Ovale

## Interventions

- **PROCEDURE:** the transcatheter closure of PFO

## Key facts

- **NCT ID:** NCT02777359
- **Lead sponsor:** First Affiliated Hospital Xi'an Jiaotong University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01
- **Primary completion:** 2018-01
- **Final completion:** 2018-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2017-07-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02777359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02777359, "Precutaneous High Risk Patent Foramen Ovale to Treat Migraine Headaches". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02777359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*